Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-244905
Filing Date
2021-08-12
Accepted
2021-08-12 17:22:30
Documents
4
Effectiveness Date
2021-08-12

Document Format Files

Seq Description Document Type Size
1 S-8 d180283ds8.htm S-8 80531
2 EX-5.1 d180283dex51.htm EX-5.1 7653
3 EX-23.1 d180283dex231.htm EX-23.1 1648
4 GRAPHIC g180283g63y17.jpg GRAPHIC 3905
  Complete submission text file 0001193125-21-244905.txt   96360
Mailing Address 23515 NE NOVELTY HILL RD., SUITE B221 #1 REDMOND WA 98077
Business Address 23515 NE NOVELTY HILL RD., SUITE B221 #1 REDMOND WA 98077 16502240857
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258771 | Film No.: 211168808
SIC: 2834 Pharmaceutical Preparations